Björn Dahlbäck
1 – 100 of 274
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Natural anticoagulant discovery, the gift that keeps on giving : finding FV-Short
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Classic Thrombophilias and Thrombotic Risk Among Middle-Aged and Older Adults : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
The preAR2 region (1458–1492) in factor V-Short is crucial for the synergistic TFPIα-cofactor activity with protein S and the assembly of a trimolecular factor Xa-inhibitory complex comprising FV-Short, protein S, and TFPIα
(
- Contribution to journal › Article
-
Mark
A hydrophobic patch (PLVIVG; 1481–1486) in the B-domain of factor V-short is crucial for its synergistic TFPIα-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIα, and protein S
(
- Contribution to journal › Article
-
Mark
Diagnosis and management of severe congenital protein C deficiency (SCPCD) : Communication from the SSC of the ISTH
(
- Contribution to journal › Article
- 2021
-
Mark
Pleiotropic anticoagulant functions of protein S, consequences for the clinical laboratory. Communication from the SSC of the ISTH
(
- Contribution to journal › Article
- 2020
-
Mark
Reduced Apolipoprotein M and Adverse Outcomes across the Spectrum of Human Heart Failure
(
- Contribution to journal › Article
-
Mark
Advances in understanding mechanisms of thrombophilic disorders
(
- Contribution to journal › Scientific review
-
Mark
Genetic risk factors for venous thromboembolism
(
- Contribution to journal › Scientific review
- 2019
-
Mark
New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short
(
- Contribution to journal › Article
-
Mark
Plasma Apolipoprotein M and Sphingosine-1-Phosphate Levels are Inversely Associated with Mortality in African Americans with Type 2 Diabetes Mellitus
(
- Contribution to journal › Article
-
Mark
Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2018
-
Mark
Vitamin K–Dependent Protein S : Beyond the Protein C Pathway
(
- Contribution to journal › Article
-
Mark
Evaluation of Expression Level of Apolipoprotein M as a Diagnostic Marker for Primary Venous Thromboembolism
(
- Contribution to journal › Article
-
Mark
High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate
(
- Contribution to journal › Article
-
Mark
Treating hemophilia by targeting protein S?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Lean ApoM−/− Mice with Hyperactive Brown Adipose Tissue
(
- Contribution to journal › Article
- 2017
-
Mark
High-Density Lipoprotein–Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1
(
- Contribution to journal › Article
-
Mark
HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium
(
- Contribution to journal › Article
-
Mark
Diminished airway macrophage expression of the Axl receptor tyrosine kinase is associated with defective efferocytosis in asthma
(
- Contribution to journal › Letter
-
Mark
Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S
(
- Contribution to journal › Article
-
Mark
The nanoparticle protein corona formed in human blood or human blood fractions
(
- Contribution to journal › Article
-
Mark
A Shift in ApoM/S1P between HDL-Particles in Women with Type 1 Diabetes Mellitus Is Associated with Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex
(
- Contribution to journal › Article
-
Mark
Gas6-Axl signaling in presence of Sunitinib is enhanced, diversified and sustained in renal tumor cells, resulting in tumor-progressive advantages
(
- Contribution to journal › Article
-
Mark
Implications of cerebrovascular ATP-binding cassette transporter G1 (ABCG1) and apolipoprotein M in cholesterol transport at the blood-brain barrier
(
- Contribution to journal › Article
-
Mark
Factor V-short and protein S as synergistic tissue factor pathway inhibitor (TFPIα) cofactors
(
- Contribution to journal › Article
- 2016
-
Mark
Urinary apolipoprotein M as a biomarker of acute kidney injury in children undergoing heart surgery.
(
- Contribution to journal › Article
-
Mark
Gas6 fueling tumor-mediated thrombosis.
(
- Contribution to journal › Article
-
Mark
Epidemiology of Familial Aggregation of Venous Thromboembolism
(
- Contribution to journal › Scientific review
-
Mark
Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders
(
- Contribution to journal › Article
-
Mark
Familial hypercholesterolaemia : cholesterol efflux and coronary disease
(
- Contribution to journal › Article
-
Mark
The Gas6-Axl Interaction Mediates Endothelial Uptake of Platelet Microparticles
(
- Contribution to journal › Article
-
Mark
Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism
(
- Contribution to journal › Article
-
Mark
Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons
(
- Contribution to journal › Article
- 2015
-
Mark
The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.
(
- Contribution to journal › Article
-
Mark
Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.
(
- Contribution to journal › Article
-
Mark
HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.
(
- Contribution to journal › Article
-
Mark
Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation.
(
- Contribution to journal › Article
-
Mark
Protein Unfolding allow use of Commercial Antibodies in an Apolipoprotein M sandwich ELISA.
(
- Contribution to journal › Article
- 2014
-
Mark
Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.
(
- Contribution to journal › Article
-
Mark
The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M and the risk of unprovoked recurrent venous thromboembolism.
(
- Contribution to journal › Article
-
Mark
Size-Dependent Effects of Nanoparticles on Enzymes in the Blood Coagulation Cascade.
(
- Contribution to journal › Article
-
Mark
The association between apolipoprotein M and insulin resistance varies with country of birth.
(
- Contribution to journal › Article
-
Mark
Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.
(
- Contribution to journal › Article
-
Mark
TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain
(
- Contribution to journal › Article
-
Mark
Targeting exosites of activated protein C as therapeutic possibility?
(
- Contribution to journal › Debate/Note/Editorial
- 2013
-
Mark
Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation
(
- Contribution to journal › Article
-
Mark
Coagulation factor V-A2440G causes east Texas bleeding disorder via TFPI alpha
(
- Contribution to journal › Article
- 2012
-
Mark
Small and large PROS1 deletions but no other types of rearrangements detected in patents with protein S deficiency
(
- Contribution to journal › Article
-
Mark
Biocompatibility of mannan nanogel-safe interaction with plasma proteins
(
- Contribution to journal › Article
-
Mark
Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes
(
- Contribution to journal › Article
-
Mark
The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL
(
- Contribution to journal › Article
-
Mark
Coagulation and inflammation-close allies in health and disease.
(
- Contribution to journal › Article
-
Mark
Polystyrene nanoparticles affecting blood coagulation.
(
- Contribution to journal › Article
- 2011
-
Mark
C4b-Binding Protein: A Forgotten Factor in Thrombosis and Hemostasis
(
- Contribution to journal › Article
-
Mark
Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels: modification by adiposity in nondiabetic subjects
(
- Contribution to journal › Published meeting abstract
-
Mark
Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis
(
- Contribution to journal › Article
-
Mark
Structural Changes in Apolipoproteins Bound to Nanoparticles
(
- Contribution to journal › Article
-
Mark
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
(
- Contribution to journal › Article
-
Mark
Activated protein C cofactor function of protein S: a novel role for a gamma-carboxyglutamic acid residue
(
- Contribution to journal › Article
-
Mark
Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels in non-diabetic subjects
(
- Contribution to journal › Letter
-
Mark
Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus.
(
- Contribution to journal › Article
- 2010
-
Mark
Mouse ApoM Displays an Unprecedented Seven-Stranded Lipocalin Fold: Folding Decoy or Alternative Native Fold?
(
- Contribution to journal › Article
-
Mark
Umbilical cord plasma levels of growth-arrest specific protein 6 in intrauterine growth restriction
(
- Contribution to journal › Article
-
Mark
The D2194G mutation is responsible for increased levels of FV1 in carriers of the factor V R2 haplotype
(
- Contribution to journal › Letter
-
Mark
ACTIVE PHOSPHOLIPID TRANSFER PROTEIN (PLTP) REDUCES PROTHROMBIN ACTIVATION AND ATTENUATES BLOOD COAGULATION
2010) 78th Congress of the European-Atherosclerosis-Society In Atherosclerosis Supplements 11(2). p.233-233(
- Contribution to journal › Published meeting abstract
-
Mark
Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men
(
- Contribution to journal › Article
-
Mark
Dependence on Vitamin K-dependent Protein S for Eukaryotic Cell Secretion of the beta-Chain of C4b-binding Protein
(
- Contribution to journal › Article
-
Mark
Gas6 is complexed to soluble tyrosine kinase receptor Axl in human blood.
(
- Contribution to journal › Article
-
Mark
Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain
(
- Contribution to journal › Article
-
Mark
Novel APC-cleavage sites in FVa providing insights into mechanisms of action of APC and its cofactor protein S.
(
- Contribution to journal › Article
-
Mark
Inhibition of Thrombin Formation by Active Site Mutated (S360A) Activated Protein C
(
- Contribution to journal › Article
-
Mark
Growth arrest specific protein 6 (gas6) and its receptors expression and signalling in beta cells
2010) 46th Annual Meeting of the European-Association-for-the- Study-of-Diabetes (EASD) In Diabetologia 53(Suppl. 1). p.530-530(
- Contribution to journal › Published meeting abstract
-
Mark
Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes
(
- Contribution to journal › Article
-
Mark
Plasma concentrations of apolipoproteins A-I, B, and M in patients with abdominal aortic aneurysms.
(
- Contribution to journal › Article
-
Mark
Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus
(
- Contribution to journal › Article
-
Mark
Tensin2 reduces intracellular phosphatidylinositol 3,4,5-trisphosphate levels at the plasma membrane.
(
- Contribution to journal › Article
-
Mark
Plasma concentrations of apolipoproteins A-I, B, and M in patients with critical limb ischemia.
(
- Contribution to journal › Article
-
Mark
The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes.
(
- Contribution to journal › Article
-
Mark
Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia.
(
- Contribution to journal › Article
-
Mark
HDL Stimulates apoM Secretion.
(
- Contribution to journal › Article
-
Mark
Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl as markers of large abdominal aortic aneurysms.
(
- Contribution to journal › Article
-
Mark
Reevaluation of the role of HDL in the anticoagulant activated protein C system in humans.
(
- Contribution to journal › Article
-
Mark
An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA.
(
- Contribution to journal › Article
-
Mark
Opposing Effects of Apolipoprotein M on Catabolism of Apolipoprotein B-Containing Lipoproteins and Atherosclerosis.
(
- Contribution to journal › Article
-
Mark
Individual domains of Tensin2 exhibit distinct subcellular localisations and migratory effects.
(
- Contribution to journal › Article
-
Mark
Plasma levels of apolipoprotein M in normal and complicated pregnancy.
(
- Contribution to journal › Article
- 2009
-
Mark
Relationship Between Plasma Apolipoprotein-M And High Density Lipoprotein Apoa Kinetics In Men
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.729-729(
- Contribution to journal › Published meeting abstract
-
Mark
Apolipoprotein M is decreased in type 2 diabetes and affects pre beta high density lipoprotein formation and cellular cholesterol efflux
(
- Contribution to journal › Published meeting abstract
-
Mark
Plasma apolipoprotein M is reduced in metabolic syndrome but does not predict intima media thickness
(
- Contribution to journal › Article
-
Mark
Protein GAS6 and its receptor Axl are expressed and operate in pancreatic beta cells
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.448-448(
- Contribution to journal › Published meeting abstract
-
Mark
Platelet Factor 4 Impairs the Anticoagulant Activity of Activated Protein C
(
- Contribution to journal › Article
-
Mark
ApoM: gene regulation and effects on HDL metabolism
(
- Contribution to journal › Scientific review
-
Mark
Anticoagulant Properties Of Apolipoprotein A-I And Phospholipid Transfer Protein
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.138-138(
- Contribution to journal › Published meeting abstract
-
Mark
Serendipitous Fatty Acid Binding Reveals the Structural Determinants for Ligand Recognition in Apolipoprotein M
(
- Contribution to journal › Article
-
Mark
Expression Of Apolipoprotein M In Fetal Liver: Impact Of Maternal Diabetes
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.714-714(
- Contribution to journal › Published meeting abstract
-
Mark
Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma.
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects
(
- Contribution to journal › Article